C5AR2
Basic information
Region (hg38): 19:47332175-47347329
Previous symbols: [ "GPR77" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (76 variants)
- not_provided (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C5AR2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001271749.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 2 | 5 | |||
| missense | 68 | 6 | 3 | 77 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 68 | 9 | 5 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| C5AR2 | protein_coding | protein_coding | ENST00000595464 | 1 | 11203 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.246 | 0.652 | 125634 | 0 | 12 | 125646 | 0.0000478 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.146 | 214 | 208 | 1.03 | 0.0000151 | 2092 |
| Missense in Polyphen | 61 | 63.127 | 0.9663 | 726 | ||
| Synonymous | -0.726 | 110 | 101 | 1.09 | 0.00000759 | 794 |
| Loss of Function | 1.19 | 1 | 3.35 | 0.298 | 2.32e-7 | 27 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000546 | 0.0000544 |
| Finnish | 0.0000521 | 0.0000462 |
| European (Non-Finnish) | 0.0000534 | 0.0000528 |
| Middle Eastern | 0.0000546 | 0.0000544 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for the chemotactic and inflammatory C3a, C4a and C5a anaphylatoxin peptides and also for their dearginated forms ASP/C3adesArg, C4adesArg and C5adesArg respectively. Couples weakly to G(i)-mediated signaling pathways. {ECO:0000269|PubMed:11773063, ECO:0000269|PubMed:15833747, ECO:0000269|PubMed:19615750}.;
- Pathway
- GPCRs, Other;Human Complement System;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Innate Immune System;Immune System;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Regulation of Complement cascade;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.7
Haploinsufficiency Scores
- pHI
- 0.0520
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- C5ar2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- complement receptor mediated signaling pathway;chemotaxis;inflammatory response;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;regulation of complement activation;negative regulation of tumor necrosis factor production;complement component C5a signaling pathway;positive regulation of epithelial cell proliferation;positive regulation of ERK1 and ERK2 cascade;negative regulation of neutrophil chemotaxis;negative regulation of interleukin-6 secretion;regulation of interleukin-8 secretion
- Cellular component
- plasma membrane;basal plasma membrane;integral component of membrane;apical part of cell
- Molecular function
- complement component C5a receptor activity;G protein-coupled receptor activity;protein binding